Skip to main content
Dean Kereiakes, MD, Cardiology, Cincinnati, OH

DeanKereiakesMD

Cardiology Cincinnati, OH

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Clinical Professor of Medicine, Ohio State University

Dr. Kereiakes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kereiakes' full profile

Already have an account?

  • Office

    2123 Auburn Avenue
    Cincinnati, OH 45219
    Phone+1 513-585-0215

Summary

  • Dean J. Kereiakes, M.D., FACC, MSCAI is Chairman of The Christ Hospital Heart and Vascular Institute, Medical Director of the Christ Hospital Research Institute, and Professor of Clinical Medicine at The Ohio State University. Dr. Kereiakes has been an original investigator for most of the interventional technologies introduced in the last three decades and has performed more than 30,000 catheterization laboratory procedures. In addition to lecturing nationally and internationally, Dr. Kereiakes is active as a scientific investigator and has participated in over 1,600 clinical research protocols. He has published over 1,000 scientific journal articles, abstracts and book chapters. He has served on the editorial boards of Circulation, The Journal of the American College of Cardiology (JACC), Journal of the American College of Cardiology Cardiovascular Interventions, The American Heart Journal, The American Journal of Cardiology and is currently Deputy Editor for Journal of The Society for Cardiac Angiography and Intervention (JSCAI). He was previously Section Editor for Circulation and received the Simon Dack Award for Outstanding Scholarship from JACC in 2011. He was awarded an Honorary Doctorate of Sciences from University of Cincinnati in 2014 and was named an Outstanding Alumnus of U.C. College of Medicine.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Cardiovascular Disease, 1982 - 1984
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1980 - 1981
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1978 - 1980
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - 2026
  • OH State Medical License
    OH State Medical License 1984 - 2026
  • IN State Medical License
    IN State Medical License 1989 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • National Board of Physicians and Surgeons Cardiovascular Disease
  • National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

  • Fellow Society of Cardiac Angiography & Intervention
  • America's Top Doctors Castle Connolly, 2002-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Drug-Coated Balloons for in-Stent Restenosis  
    Dean Kereiakes, MD, JACC: Cardiovascular Imaging

Lectures

  • Overview of Expanding Applications 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
  • Final 5-Year Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated Everolimus-Eluting SYNERGY Stent 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Interventional Live Case Session IV: Coronary Transmission from University of Washington Medical Center 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • Bioresorbable Vascular Scaffolds: Why and How?October 2019
  • Bioresorbable Vascular Scaffolds: Why and How?October 2019
  • New Insights into Bioresorbable Vascular Scaffolds Gained from Longer-Term Follow-UpOctober 2018
  • New Insights into Bioresorbable Vascular Scaffolds Gained from Longer-Term Follow-UpOctober 2018
  • Join now to see all

Press Mentions

  • Christ Hospital Surgeons Perform Fourth-in-the-World Implant of the BiVACOR Total Artificial Heart
    Christ Hospital Surgeons Perform Fourth-in-the-World Implant of the BiVACOR Total Artificial HeartNovember 15th, 2024
  • Ancora Heart Inc. And Egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
    Ancora Heart Inc. And Egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure PatientsApril 20th, 2023
  • Christ Hospital Health Network Launches Region's Second Adult Heart Transplant Program
    Christ Hospital Health Network Launches Region's Second Adult Heart Transplant ProgramOctober 6th, 2022
  • Join now to see all

Research History

  • Medical Director, The Christ Hospital Research Institute

Professional Memberships